SA

Shahid Ahmad

Active Director Director DIN 08835075
DIN 08835075 First appointment Aug 2020 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Shahid Ahmad

Data last updated:

Shahid Ahmad is a Director at Curb N Care Pharmaceuticals Private Limited (since 2020). The company operates in Business Services. Curb N Care Pharmaceuticals Private Limited reported revenue of ₹59.8 Lakh (FY 2024).

DIN 08835075
Primary Designation Director
Industry Business Services
First Appointment 14 Aug 2020
Oldest Company Age 6 yrs
Largest company Curb N Care Pharmaceuticals Private Limited · ₹59.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Aug 20202020₹59.8 Lakh (FY 2024)Active

Board colleagues of Shahid Ahmad

Directorship timeline

Open interactive timeline →
Curb N Care Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shahid Ahmad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shahid Ahmad

Shahid Ahmad currently holds 1 directorship: Curb N Care Pharmaceuticals Private Limited (Director, since 14 Aug 2020, revenue ₹59.8 Lakh (FY 2024)).

Shahid Ahmad was first appointed on 14 Aug 2020 as Director at Curb N Care Pharmaceuticals Private Limited.

The current boards of Shahid Ahmad's companies include Mohammad Isteyaque Ahmad (Curb N Care Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available